Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Echis ocellatus disintegrins are a family of small, cysteine-rich, non-enzymatic proteins found in the venom of the West African carpet viper, Echis ocellatus [1, 2]. These molecules are primarily known for their potent ability to inhibit platelet aggregation and cell-matrix interactions by binding to integrin receptors, such as the fibrinogen receptor (alpha-IIb-beta-3) and the vitronectin receptor (alpha-v-beta-3) [3, 4]. Most members of this family contain a conserved Arg-Gly-Asp (RGD) motif that mimics the binding sites of natural extracellular matrix ligands, allowing them to act as competitive antagonists [1, 5]. In the context of snakebite pathology, these disintegrins contribute significantly to the venom-induced consumption coagulopathy and systemic hemorrhage by preventing the formation of stable platelet plugs [2, 6]. Beyond their role as toxins, they have been extensively studied as pharmacological tools and lead compounds for developing anti-thrombotic and anti-angiogenic therapies [4, 7]. Their high affinity and specificity for integrins make them valuable for investigating cell signaling and potential treatments for cancer metastasis [3, 8].
Antivenom antibodies bind to the disintegrin molecules, sterically hindering their ability to interact with cellular integrins and facilitating their clearance from circulation [2, 6, 8].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Echis ocellatus disintegrins.